Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ATAI Life Sciences (ATAI)
NASDAQ:ATAI
ATAI Life Sciences (ATAI) Stock Price & Analysis
734 Followers
ATAI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.03 - $2.85
Previous Close$2.3
Volume1.75M
Average Volume (3M)1.62M
Market Cap
$381.86M
Enterprise Value$354.22M
Total Cash (Recent Filing)$45.03M
Total Debt (Recent Filing)$16.04M
Price to Earnings (P/E)-9.0
Beta1.35
Next Earnings
May 13, 2024EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding166,026,396
10 Day Avg. Volume3,189,393
30 Day Avg. Volume1,623,617
Standard Deviation0.17
R-Squared0.09
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)1.57
Price to Sales (P/S)1216.12
Price to Cash Flow (P/CF)-4.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.13K
Enterprise Value/Gross Profit1.13K
Enterprise Value/Ebitda-9.53
Forecast
1Y Price Target
$10.67Price Target Upside415.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
ATAI Life Sciences News
Ownership Overview
34.05% Insiders
0.68% Mutual Funds
2.45% Other Institutional Investors
62.81% Public Companies and Individual Investors
ATAI FAQ
What was ATAI Life Sciences’s price range in the past 12 months?
ATAI Life Sciences lowest stock price was $1.02 and its highest was $2.85 in the past 12 months.
What is ATAI Life Sciences’s market cap?
Currently, no data Available
When is ATAI Life Sciences’s upcoming earnings report date?
ATAI Life Sciences’s upcoming earnings report date is May 13, 2024 which is in 27 days.
How were ATAI Life Sciences’s earnings last quarter?
ATAI Life Sciences released its earnings results on Mar 28, 2024. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.152 by $0.032.
Is ATAI Life Sciences overvalued?
According to Wall Street analysts ATAI Life Sciences’s price is currently Undervalued.
Does ATAI Life Sciences pay dividends?
ATAI Life Sciences does not currently pay dividends.
What is ATAI Life Sciences’s EPS estimate?
ATAI Life Sciences’s EPS estimate is -$0.18.
How many shares outstanding does ATAI Life Sciences have?
ATAI Life Sciences has 166,026,400 shares outstanding.
What happened to ATAI Life Sciences’s price movement after its last earnings report?
ATAI Life Sciences reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.152. Following the earnings report the stock price went up 10.056%.
Which hedge fund is a major shareholder of ATAI Life Sciences?
Among the largest hedge funds holding ATAI Life Sciences’s share is Lumina Fund Management Llc. It holds ATAI Life Sciences’s shares valued at N/A.
---
ATAI Life Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.67 (415.46% Upside)
$10.67 (415.46% Upside)
Blogger Sentiment
Bullish
ATAI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 17.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $231.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.37%
12-Months-Change
Fundamentals
Return on Equity
-15.97%
Trailing 12-Months
Asset Growth
-3.92%
Trailing 12-Months
Company Description
ATAI Life Sciences
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine.
---
ATAI Stock 12 Months Forecast
Average Price Target
$10.67
▲(415.46% Upside)
Technical Analysis
Best Analysts Covering ATAI
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+5.58%
reiterated a buy rating 8 months ago
Copying Caroline Palomeque's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.58% per trade.
---